Jpmorgan Chase & CO Kaleido Biosciences, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$0.05 - $1.7 $459 - $15,634
-9,197 Closed
0 $0
Q1 2022

May 11, 2022
BUY
$1.3 - $2.7 $2,142 - $4,449
1,648 Added 21.83%
9,197 $15,000
Q4 2021

Feb 10, 2022
SELL
$2.39 - $6.02 $7,148 - $18,005
-2,991 Reduced 28.38%
7,549 $18,000
Q3 2021

Nov 12, 2021
BUY
$5.36 - $7.99 $56,494 - $84,214
10,540 New
10,540 $58,000

Others Institutions Holding KLDO

# of Institutions
2
Shares Held
2.65K
Call Options Held
0
Put Options Held
0
View Full List

About Kaleido Biosciences, Inc.

KLDO Quotes by TradingView
  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email